We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Gent takes a seat

26 May 2004 By Robert Cyran

Gent brings two qualities to the chair of the UK pharmaceuticals group a silver tongue and a penchant for deals. But given Glaxo’s lowly valuation, he’ll need to talk up its prospects before he gets stuck into M&A.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)